Life Tech Reports Increase in CE Business for Research and Clinical Labs, Strong Growth in SOLiD Sales in Q2

In total, the company's genetic systems business, which includes both CE and next-gen sequencing, booked non-GAAP revenues of $235 million, up 5 percent over the same period last year, and 7 percent organically.